Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of disease
Open Access
- 5 June 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 10 (6), 738-741
- https://doi.org/10.1093/ckj/sfx045
Abstract
Fibrillary glomerulonephritis (FGN) is a rare immune complex type glomerulonephritis characterized by glomerular deposition of randomly oriented fibrils measuring 10–30 nm in thickness, and typically presents with proteinuria with or without renal insufficiency and hematuria. We present a case in which a patient initially presented at age 41 years with nephrotic-range proteinuria and hypertension; a kidney biopsy showed FGN. The patient was treated with angiotensin receptor blockage only, without immunosuppression as per patient preference, and the level of protein in the urine improved. During the follow-up period of 17 years, the patient developed type 2 diabetes mellitus. The patient re-presented with nephrotic-range proteinuria 17 years later, at the age of 58 years. A kidney biopsy was performed and showed diffuse diabetic glomerulosclerosis with secondary focal segmental glomerulosclerosis and related vascular changes. There was no evidence of FGN by immunofluorescence or electron microscopy. Although FGN has been rarely reported to regress clinically, this is the first documented case of histologic regression of FGN. The potential for FGN fibrils to regress spontaneously is important in the management of FGN patients considering that currently available immunosuppressive agents have limited efficacy, and is an encouraging finding for future studies aiming to find a cure for the disease.Keywords
This publication has 15 references indexed in Scilit:
- Plasmapheresis leading to remission of refractory nephrotic syndrome due to fibrillary glomerulonephritis: a case reportJournal of Medical Case Reports, 2012
- Fibrillary GlomerulonephritisClinical Journal of the American Society of Nephrology, 2011
- Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantationClinical and Experimental Nephrology, 2009
- Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary depositsKidney International, 2009
- Rituximab Treatment of Fibrillary GlomerulonephritisAmerican Journal of Kidney Diseases, 2008
- Fibrillary Glomerulonephritis and Immunotactoid GlomerulopathyJournal of the American Society of Nephrology, 2008
- Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic featuresKidney International, 2003
- Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathyNephrology Dialysis Transplantation, 1996
- Morphologic and Clinical Features of Fibrillary Glomerulonephritis Versus Immunotactoid GlomerulopathyAmerican Journal of Kidney Diseases, 1993
- Clinical and pathologic features of fibrillary glomerulonephritisKidney International, 1992